NDRA vs WAT · P/E 0.0, $2.6M cap vs P/E 32, rev $1.65B
ENDRA Life Sciences Inc (NDRA) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
NDRA does not have a complete income-statement cache yet.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
NDRA currently screens at market cap $2.6M and trailing P/E 0.0. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the NDRA and WAT stock pages for the full models.
Not investment advice.